News
Schizophrenia and HIV: missed opportunities for care
Current guidelines need to reflect the role that patients with HIV and psychiatric comorbidities play in HIV transmission.
News
Breastfeeding disparities further exacerbated by pending legislation
For hundreds of years, African American women demonstrated that it takes a village, especially when it comes to breastfeeding.
News
HIV stigma persists globally, according to Harris poll
Pervasive stereotypes and stigmatization only serve to magnify preexisting social inequities that affect access to appropriate care.
News
OTC cannabidiol products tied to improved pain, sleep, anxiety
“There are some data to suggest that there is an expectancy effect when we talk about the therapeutic benefit of cannabinoid products,” said Dr....
News
Clinician experience, life stressors drive HIV adherence, retention in new patients
“Patients who reported better initial experiences with their provider at the first visit were less likely to be lost to follow-up,” said Dr....
News
FDA approves cabotegravir LA; New HIV PrEP option fills an important gap
“Being able to offer an injectable option is ... a game changer,” said Dr. Lina Rosengren-Hovee of UNC Health.
News
HIV prescription mandate controversy reaches the Supreme Court
A firestorm of controversy over access to HIV medications and protection against discriminatory insurance practices has been making its way...
News
ANCHOR study findings may usher in new care standards for anal cancer in HIV-infected patients
“A lot of people with HIV have these high-grade lesions. If we were able to identify who’s at highest risk of all of them, that would be very...
News
COVID-19 causes major interruption in global HIV progress
“We’ve been set back by COVID but we’ve seen remarkable resilience, a lot of innovation and creativity.”
News
Guideline gives weak support to trying oral medical cannabis for chronic pain
Does oral medical cannabis work in chronic pain? Here’s what the evidence says.
News
Injectable cabotegravir PrEP superior to oral TDF-FTC; trial halted early
“The reason that we were able to show that cabotegravir was superior is because we enrolled a very young, very highly at-risk, very underresourced...
News
Neurologists brace and prepare for long-COVID fallout
Data that have accumulated since the COVID-19 outbreak suggest that at least 1 in 3 people who are initially infected may be long-haulers.